Navigation Links
Bio-Solutions Corp. Expanding in Booming Diabetes Market
Date:8/29/2013

CORAL SPRINGS, Florida, August 29, 2013 /PRNewswire/ --

On Wednesday, Bio-Solutions Corp. (OTCQB: BISU) announced their Direct Response Infomercial and Marketing Campaign for its flagship product, Type2Defense. Over 30 million people suffer from Type 2 diabetes in the United States, according to seeking alpha. Additionally, it's forecasted that nearly 30 percent of the U.S.'s population will have diabetes by 2050, with most of that percentage facing Type 2.

United Healthcare predicts spending on diabetes will grow significantly over the next 10 years, estimating that the country will spend around $3.4 trillion on the disease. The total cost of diagnosed diabetes in 2012 was $245 billion, as stated by the American Diabetes Association. This was a 41 percent increase from 2007, when costs reached $174 billion.

Bio-Solutions' Type2 Defense is a powder blend of natural ingredients that has been developed to help support healthy blood glucose levels in health-conscious individuals and those diagnosed with Type II Diabetes. With the launch of Type 2 Defense's new infomercial and marketing campaign, BISU takes a significant step in their expansion across the U.S.

The partnership with Direct Response Marketing isn't the first step Bio-Solutions has taken in effort to expand, as they also recently announced they have begun a campaign on Lockerdome.com. Lockerdome.com is the premier destination on the internet for both professional and amateur athletes, with monthly traffic in excess of 14 million visitors. The Company's campaign on the website will allow young athletes with diabetes to interact with pro athletes also suffering from the disease.

For more recent news for BISU, please click on the following links:

http://finance.yahoo.com/news/bio-solutions-corporation-announces-campaign-113000206.html

http://finance.yahoo.com/news/bio-solutions-corporation-launches-type2defense-150000680.html

About Bio-Solutions Corp.

Bio-Solutions Corp. markets new and very effective organic products; our lead product is Type2 Defense™. Type2Defense™ a Diabetic Supplement Drink. Type2Defense™ is a new dietary supplement that has been developed to help support healthy blood glucose levels in health-conscious individuals and those diagnosed with Type 2 Diabetes. The Product's goal is to provide a safe and natural supplement that will assist in the stabilization of healthy glucose levels along with providing strong antioxidants. Consumers can find more information about the company and its products by going to http://www.BioSolutionsCorp.com.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements which address actual results could differ materially from those expressed or implied in forward-looking statements. These statements are made on the basis of management's views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as management "believes", "expects", "anticipates", "foresees", "forecasts", "estimates" or other words or phrases of similar import. Similarly, statements in this release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward looking statements. Management cautions that the ability to attract clients and generate business may be affected by a decline in the Company's financial ratings, the competitive environment, the Company's ability to raise sufficient capital to meet the collateral requirements associated with its current business and to fund the Company's continuing operations and changes in market conditions.

Investor Relations Contact
William Gallagher
+1-210-218-4475
info@biosolutionscorp.com

Contact:
FN Media Group, LLC
+1-954-345-0611
editor@financialnewsmedia.com



'/>"/>
SOURCE FN Media Group LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Healthcare Briefing - Leading Medical Companies in the News: Bio-Solutions, Catalyst Pharmaceutical, MannKind, Amgen, Accuray
2. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
3. SolutionStart Corp. Announces John Karagiannis as Vice President of Technology
4. BioSpecifics Technologies Corp. Announces Rescheduled First Quarter 2012 Financial Results Conference Call to May 10, 2012
5. ThermoGenesis Corp. To Announce Third Quarter Fiscal 2012 Results On May 10, 2012
6. Millennium Surgical Corp. Announces Sales Figures, Growth
7. Millennium Surgical Corp. Develops Online Sterilization Resource Center
8. Rittal Corp. Joins the HP ProActive Insight Architecture Alliance
9. Actinium Pharmaceuticals Inc. Pays Regulatory Milestone to Abbott Biotherapeutics Corp.
10. BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2012 Financial Results on August 9, 2012
11. Online Pharmacy Domain Policy Changes Announced by ICANN Registrar Internet.bs Corp.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... New York , January 23, 2017 ... Non-Invasive Prenatal Testing Market was valued at US$0.53 bn in ... expanding at a strong 17.50% CAGR between 2014 and 2022. The ... Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast 2014 ... Non-invasive ...
(Date:1/23/2017)... The global  anxiety disorders and depression treatment market  is ... incidence of depression worldwide is anticipated to drive the market growth in the ... demand for antidepressants in the recent years. Continue ... ... ...
(Date:1/23/2017)... SAN DIEGO , 23. Januar 2017  ResMed ... China ) und 3B Medical ( Winter ... sich auf eine Vereinbarung über die Beilegung aller globalen ... ist der Verkauf ihrer bestehenden Produkte im ... eine einmalige Zahlung an 3B leisten, um das in ...
Breaking Medicine Technology:
(Date:1/23/2017)... ... January 23, 2017 , ... A Northwestern Pennsylvania ... domain address. Alpine Springs Rehabilitation & Recovery Center’s new website can be found ... along with its redesigned and retooled website. The treatment center has also revamped ...
(Date:1/23/2017)... ... 2017 , ... Ultimate Medical Academy today announced the keynote ... March 23-25, 2017 in Tampa, and reminded educators and education leaders to submit ... Dr. Michelle R. Weise, executive director of the Sandbox Collaborative, the R&D arm ...
(Date:1/23/2017)... ... ... and plastic balance boards have been around since at least the 1950s and are a ... first and only balance board to use a patent-pending design featuring high-pressure inflation technology and ... as well as skill-level adjustable for all ages and abilities. The board can be ...
(Date:1/23/2017)... (PRWEB) , ... January 23, 2017 , ... ... the premiere organization in North America for the scientific development, healthcare training and ... Annual Scientific Session, and its 2017 AAT Member Certification Qualification Courses for Technicians, ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... However, choosing the right method is paramount to success. Selecting an inappropriate measurement ... situations where multiple persons use the same equipment. Rare or expensive substances are ...
Breaking Medicine News(10 mins):